Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries
Up to 80% of antibiotics are prescribed in the community. An assessment of prescribing by indication will help to identify areas where improvement can be made. A point prevalence audit study (PPAS) of consecutive respiratory tract infection (RTI) consultations in general practices in 13 European cou...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/12/3/572 |
| _version_ | 1797613879448043520 |
|---|---|
| author | Akke Vellinga Addiena Luke-Currier Nathaly Garzón-Orjuela Rune Aabenhus Marilena Anastasaki Anca Balan Femke Böhmer Valerija Bralić Lang Slawomir Chlabicz Samuel Coenen Ana García-Sangenís Anna Kowalczyk Lile Malania Angela Tomacinschii Sanne R. van der Linde Emily Bongard Christopher C. Butler Herman Goossens Alike W. van der Velden |
| author_facet | Akke Vellinga Addiena Luke-Currier Nathaly Garzón-Orjuela Rune Aabenhus Marilena Anastasaki Anca Balan Femke Böhmer Valerija Bralić Lang Slawomir Chlabicz Samuel Coenen Ana García-Sangenís Anna Kowalczyk Lile Malania Angela Tomacinschii Sanne R. van der Linde Emily Bongard Christopher C. Butler Herman Goossens Alike W. van der Velden |
| author_sort | Akke Vellinga |
| collection | DOAJ |
| description | Up to 80% of antibiotics are prescribed in the community. An assessment of prescribing by indication will help to identify areas where improvement can be made. A point prevalence audit study (PPAS) of consecutive respiratory tract infection (RTI) consultations in general practices in 13 European countries was conducted in January–February 2020 (PPAS-1) and again in 2022 (PPAS-4). The European Surveillance of Antibiotic Consumption quality indicators (ESAC-QI) were calculated to identify where improvements can be made. A total of 3618 consultations were recorded for PPAS-1 and 2655 in PPAS-4. Bacterial aetiology was suspected in 26% (PPAS-1) and 12% (PPAS-4), and an antibiotic was prescribed in 30% (PPAS-1) and 16% (PPAS-4) of consultations. The percentage of adult patients with bronchitis who receive an antibiotic should, according to the ESAC-QI, not exceed 30%, which was not met by participating practices in any country except Denmark and Spain. For patients (≥1) with acute upper RTI, less than 20% should be prescribed an antibiotic, which was achieved by general practices in most countries, except Ireland (both PPAS), Croatia (PPAS-1), and Greece (PPAS-4) where prescribing for acute or chronic sinusitis (0–20%) was also exceeded. For pneumonia in adults, prescribing is acceptable for 90–100%, and this is lower in most countries. Prescribing for tonsillitis (≥1) exceeded the ESAC-QI (0–20%) in all countries and was 69% (PPAS-1) and 75% (PPAS-4). In conclusion, ESAC-QI applied to PPAS outcomes allows us to evaluate appropriate antibiotic prescribing by indication and benchmark general practices and countries. |
| first_indexed | 2024-03-11T07:01:55Z |
| format | Article |
| id | doaj.art-c84f8add7d6c4a6b954e13e77d616beb |
| institution | Directory Open Access Journal |
| issn | 2079-6382 |
| language | English |
| last_indexed | 2024-03-11T07:01:55Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antibiotics |
| spelling | doaj.art-c84f8add7d6c4a6b954e13e77d616beb2023-11-17T09:14:56ZengMDPI AGAntibiotics2079-63822023-03-0112357210.3390/antibiotics12030572Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga0Addiena Luke-Currier1Nathaly Garzón-Orjuela2Rune Aabenhus3Marilena Anastasaki4Anca Balan5Femke Böhmer6Valerija Bralić Lang7Slawomir Chlabicz8Samuel Coenen9Ana García-Sangenís10Anna Kowalczyk11Lile Malania12Angela Tomacinschii13Sanne R. van der Linde14Emily Bongard15Christopher C. Butler16Herman Goossens17Alike W. van der Velden18School of Public Health, Physiotherapy and Sports Science, University College Dublin, D04 V1W8 Dublin, IrelandSchool of Public Health, Physiotherapy and Sports Science, University College Dublin, D04 V1W8 Dublin, IrelandSchool of Public Health, Physiotherapy and Sports Science, University College Dublin, D04 V1W8 Dublin, IrelandResearch Unit for General Practice, Department of Public Health, University of Copenhagen, DK-2200 Copenhagen, DenmarkDepartment of Social Medicine, School of Medicine, University of Crete, 71003 Heraklion, GreeceBalan Medfam Srl, 400064 Cluj Napoca, RomaniaInstitute of General Practice, Rostock University Medical Center, 18057 Rostock, GermanyDepartment of Family Medicine, “Andrija Stampar” School of Public Health, School of Medicine, University of Zagreb, 10020 Zagreb, CroatiaDepartment of Family Medicine, Medical University of Bialystok, 15-089 Bialystok, PolandDepartment of Family Medicine & Population Health, University of Antwerp, 2610 Antwerp, BelgiumInstitut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, SpainCentre for Family and Community Medicine, Faculty of Health Sciences, Medical University of Lodz, 92-213 Lodz, PolandNational Center for Disease Control and Public Health, Tbilisi and Arner Science Management LLC, 0190 Tbilisi, GeorgiaUniversity Clinic of Primary Medical Assistance, State University of Medicine and Pharmacy “Nicolae Testemițanu”, MD-2004 Chişinǎu, MoldovaJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The NetherlandsNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX1 4BH, UKNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX1 4BH, UKLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, 2610 Antwerp, BelgiumJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The NetherlandsUp to 80% of antibiotics are prescribed in the community. An assessment of prescribing by indication will help to identify areas where improvement can be made. A point prevalence audit study (PPAS) of consecutive respiratory tract infection (RTI) consultations in general practices in 13 European countries was conducted in January–February 2020 (PPAS-1) and again in 2022 (PPAS-4). The European Surveillance of Antibiotic Consumption quality indicators (ESAC-QI) were calculated to identify where improvements can be made. A total of 3618 consultations were recorded for PPAS-1 and 2655 in PPAS-4. Bacterial aetiology was suspected in 26% (PPAS-1) and 12% (PPAS-4), and an antibiotic was prescribed in 30% (PPAS-1) and 16% (PPAS-4) of consultations. The percentage of adult patients with bronchitis who receive an antibiotic should, according to the ESAC-QI, not exceed 30%, which was not met by participating practices in any country except Denmark and Spain. For patients (≥1) with acute upper RTI, less than 20% should be prescribed an antibiotic, which was achieved by general practices in most countries, except Ireland (both PPAS), Croatia (PPAS-1), and Greece (PPAS-4) where prescribing for acute or chronic sinusitis (0–20%) was also exceeded. For pneumonia in adults, prescribing is acceptable for 90–100%, and this is lower in most countries. Prescribing for tonsillitis (≥1) exceeded the ESAC-QI (0–20%) in all countries and was 69% (PPAS-1) and 75% (PPAS-4). In conclusion, ESAC-QI applied to PPAS outcomes allows us to evaluate appropriate antibiotic prescribing by indication and benchmark general practices and countries.https://www.mdpi.com/2079-6382/12/3/572auditprimary health carequality in healthcarerespiratory infectionsantibiotic prescribing |
| spellingShingle | Akke Vellinga Addiena Luke-Currier Nathaly Garzón-Orjuela Rune Aabenhus Marilena Anastasaki Anca Balan Femke Böhmer Valerija Bralić Lang Slawomir Chlabicz Samuel Coenen Ana García-Sangenís Anna Kowalczyk Lile Malania Angela Tomacinschii Sanne R. van der Linde Emily Bongard Christopher C. Butler Herman Goossens Alike W. van der Velden Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries Antibiotics audit primary health care quality in healthcare respiratory infections antibiotic prescribing |
| title | Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries |
| title_full | Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries |
| title_fullStr | Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries |
| title_full_unstemmed | Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries |
| title_short | Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries |
| title_sort | disease specific quality indicators for outpatient antibiotic prescribing for respiratory infections esac quality indicators applied to point prevalence audit surveys in general practices in 13 european countries |
| topic | audit primary health care quality in healthcare respiratory infections antibiotic prescribing |
| url | https://www.mdpi.com/2079-6382/12/3/572 |
| work_keys_str_mv | AT akkevellinga diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT addienalukecurrier diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT nathalygarzonorjuela diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT runeaabenhus diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT marilenaanastasaki diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT ancabalan diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT femkebohmer diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT valerijabraliclang diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT slawomirchlabicz diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT samuelcoenen diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT anagarciasangenis diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT annakowalczyk diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT lilemalania diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT angelatomacinschii diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT sannervanderlinde diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT emilybongard diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT christophercbutler diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT hermangoossens diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries AT alikewvandervelden diseasespecificqualityindicatorsforoutpatientantibioticprescribingforrespiratoryinfectionsesacqualityindicatorsappliedtopointprevalenceauditsurveysingeneralpracticesin13europeancountries |